From the Departments of Biotechnology.
the Departments of Clinical Pharmacology and.
J Biol Chem. 2018 Jan 19;293(3):1070-1087. doi: 10.1074/jbc.M117.814244. Epub 2017 Nov 29.
-Glycosylation plays a fundamental role in many biological processes. Human diamine oxidase (hDAO), required for histamine catabolism, has multiple glycosylation sites, but their roles, for example in DAO secretion, are unclear. We recently reported that the glycosylation sites Asn-168, Asn-538, and Asn-745 in recombinant hDAO (rhDAO) carry complex-type glycans, whereas Asn-110 carries only mammalian-atypical oligomannosidic glycans. Here, we show that Asn-110 in native hDAO from amniotic fluid and Caco-2 cells, DAO from porcine kidneys, and rhDAO produced in two different HEK293 cell lines is also consistently occupied by oligomannosidic glycans. Glycans at Asn-168 were predominantly sialylated with bi- to tetra-antennary branches, and Asn-538 and Asn-745 had similar complex-type glycans with some tissue- and cell line-specific variations. The related copper-containing amine oxidase human vascular adhesion protein-1 also exclusively displayed high-mannose glycosylation at Asn-137. X-ray structures revealed that the residues adjacent to Asn-110 and Asn-137 form a highly conserved hydrophobic cleft interacting with the core trisaccharide. Asn-110 replacement with Gln completely abrogated rhDAO secretion and caused retention in the endoplasmic reticulum. Mutations of Asn-168, Asn-538, and Asn-745 reduced rhDAO secretion by 13, 71, and 32%, respectively. Asn-538/745 double and Asn-168/538/745 triple substitutions reduced rhDAO secretion by 85 and 94%. Because of their locations in the DAO structure, Asn-538 and Asn-745 glycosylations might be important for efficient DAO dimer formation. These functional results are reflected in the high evolutionary conservation of all four glycosylation sites. Human DAO is abundant only in the gastrointestinal tract, kidney, and placenta, and glycosylation seems essential for reaching high enzyme expression levels in these tissues.
糖基化在许多生物过程中起着至关重要的作用。人类二胺氧化酶(hDAO)是组胺代谢所必需的,它有多个糖基化位点,但这些糖基化位点的作用,例如在 DAO 分泌中的作用,尚不清楚。我们最近报道,重组 hDAO(rhDAO)中的糖基化位点 Asn-168、Asn-538 和 Asn-745 携带复杂型聚糖,而 Asn-110 仅携带哺乳动物非典型寡甘露糖型聚糖。在这里,我们表明,羊水和 Caco-2 细胞中的天然 hDAO、猪肾脏中的 DAO 以及在两种不同的 HEK293 细胞系中产生的 rhDAO 中的 Asn-110 也始终被寡甘露糖型聚糖占据。Asn-168 上的聚糖主要带有二至四触角分支的唾液酸化,Asn-538 和 Asn-745 具有类似的复杂型聚糖,存在一些组织和细胞系特异性变化。相关的含铜胺氧化酶人血管黏附蛋白-1 也仅在 Asn-137 处显示高甘露糖糖基化。X 射线结构表明,Asn-110 和 Asn-137 相邻的残基形成一个高度保守的疏水性裂缝,与核心三糖相互作用。Asn-110 被 Gln 取代完全阻断了 rhDAO 的分泌,并导致其在内质网中滞留。Asn-168、Asn-538 和 Asn-745 的突变分别使 rhDAO 分泌减少了 13%、71%和 32%。Asn-538/745 双突变和 Asn-168/538/745 三突变使 rhDAO 分泌减少了 85%和 94%。由于它们在 DAO 结构中的位置,Asn-538 和 Asn-745 的糖基化可能对 DAO 二聚体的有效形成很重要。这些功能结果反映在所有四个糖基化位点的高度进化保守性上。人 DAO 仅在胃肠道、肾脏和胎盘组织中大量存在,糖基化似乎是在这些组织中达到高酶表达水平所必需的。